CLBIO — Corline Biomedical AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK272.93m
- SEK255.46m
- SEK25.03m
- 41
- 11
- 11
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.54 | -7.29 | -6.91 | 2.33 | -1.79 |
Depreciation | |||||
Changes in Working Capital | -4.31 | 2.21 | 2.04 | -8.84 | 2.58 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.8 | -5.07 | -4.83 | -6.45 | 0.886 |
Capital Expenditures | -4.84 | -8.8 | -9.62 | -9 | -10.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.056 | 0 | 0 |
Change in Net Investments | |||||
Cash from Investing Activities | -4.84 | -8.8 | -9.56 | -9 | -10.6 |
Financing Cash Flow Items | — | — | -3.51 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 13.9 | 0 | 47.1 | 0.026 | 0.537 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.79 | -13.9 | 32.7 | -15.4 | -9.2 |